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ABSTRACT
Objective: Among various environmental carcinogens, arsenic is highly sensitive and possesses potential to cause several diseases including cancer. 
Nevertheless, arsenic has not been observed to induce mutation directly but is involved in epigenetic changes. Hypomethylation of oncogenes and 
hypermethylation of tumor suppressor genes are reported to be associated with accumulation of arsenic. The present investigation demonstrates a 
direct correlation arsenic and deoxyribonucleic acid (DNA) methylation.
Methods: Swiss albino mice were grouped as control and arsenic treated for 12 weeks. Arsenic concentration in blood and testes was analyzed by 
atomic absorption spectrometer. Furthermore, DNA was extracted from the testes of mice by DNA purification kit and used for determining global 
methylation in mice genome with the help of MethylFlash Methylated DNA Quantification Kit.
Results: Arsenic concentration in arsenic-treated mice was significantly higher than the control group in both blood and testes. Interestingly, arsenic 
concentration in blood was recorded to be higher than testes in the arsenic-treated group with significance (p<0.0001). Moreover, a lower percentage 
of cytosine of mice genome was found to be methylated in arsenic-treated mice group than control group (p<0.0001).
Conclusion: Greater concentration of arsenic in mice leads to hypomethylation of mice genome globally. Arsenic fosters deregulation of gene 
expression by modifying methylation of CpG island of the promoter region. Epigenetic study is of prime importance in the field of oncology. Drug 
development for repressing alteration of DNA methylation is imperative for cancer treatment.
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INTRODUCTION
Arsenic, a metalloid released from both natural and anthropogenic 
sources, is a major health concern in many countries and has been 
associated with many human cancers [1,2]. In addition, chronic 
exposure of arsenic is also usually linked with many other diseases 
including abnormalities related to the reproductive system [3]. 
Metals such as arsenic may affect male reproductive system directly 
when it targets specific reproductive organ or indirectly when it 
targets neuroendocrine system. The deleterious effect of arsenic on 
spermatogenesis can be long lasting and irreversible if the Sertoli 
cells are damaged. The number of motile sperm produced during 
adulthood is determined by the number of Sertoli cells because each 
Sertoli cell supports the maturation of an only limited number of germ 
cells to sperm. Inorganic arsenic is an endocrine disruptor which is 
demonstrated to jeopardize the process of spermatogenesis leading 
to lower sperm count, impair the stability sperm chromatin or sperm 
deoxyribonucleic acid (DNA) damage [4].
Inorganic arsenic is primarily metabolized in the liver and converted 
to the organic entity. Thereafter, the organic arsenic is distributed to 
the entire body by peripheral blood. The excretion of arsenic has been 
observed to be miniature. According to a study, the highest amount 
of arsenic excreted was in form of monomethylarsonic acid (MMA) 
followed by dimethylarsinic acid (DMA) and inorganic arsenic [5]. An 
autoradiographic study of 74As-arsenite (As III) injected intravenously 
in mice showed the highest accumulation of arsenic in skeleton 
and long-term retention in hair and skin, squamous epithelium of 
gastrointestinal tract, the epididymis, thyroid, and lens [6]. In another 
study, 80% of the oral dosed arsenic was observed in gastrointestinal 
tract and the highest initial retention was found in kidney, lungs, 
intestinal mucosa, stomach, and testes [7].
Both genetic alteration (mutation) and epigenetic changes (methylation) 
have been linked with environmental carcinogenesis. Chronic exposure 
of low dose of arsenic to the non-tumorigenic prostate epithelial cells 
transformed to tumorigenic cells [8]. Several mechanisms at molecular 
and cellular levels have been proposed to explain the carcinogenicity 
induced by arsenic. Global DNA hypomethylation and activation of 
various oncogenes have been reported in the literature  [8,9].  If the 
arsenic, by any mean, is ingested by humans, the inorganic arsenic 
is converted to organic forms, i.e., MMA and DMA in liver [10]. Since 
methylation of inorganic arsenic is considered to be detoxification 
process evolved by our body because methylated arsenic has lower toxic 
effect as compared to that of inorganic arsenic [11,12]. The conversion 
of inorganic arsenic to DMA or MMA is catalyzed by an enzyme called 
methyltransferase. Methyltransferase is an indigenous enzyme which 
transfers methyl group from s-adenosylmethionine to cytosine of CpG 
island of the promoter region. However, in this context, methyltransferase 
transfers methyl group from inorganic arsenic to CpG island and vice 
versa leading to hypermethylation or hypomethylation of CpG island of 
various oncogenes and tumor suppressor genes. Hypermethylation and 
hypomethylation were linked to tumor suppressor gene inactivation and 
oncogene activation, respectively [13-15].
This study aims to investigate the effect of acute toxicity by arsenic on gene 
expression and attempts to establish a correlation between accumulation 
of arsenic in the body and its ability to modify the methylation pattern. 
Arsenic, a potent carcinogen, has been shown to possess the capability to 
alter gene expression at epigenetic level in this study.
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Swiss albino mice (Mus musculus) were reared in the animal house of 
S.S. Hospital and Research Institute, Patna. The male mice selected for 
the study were 12 weeks old, and their weight was measured as 30±2 g. 
The mice were kept in the polypropylene cages with paddy husk at room 
temperature 28±2°C and humidity 50±5% in a controlled light (12 hrs 
light and 12 hrs dark). Animals were maintained in ideal conditions as 
per the ethical guidelines of the CPCSEA (CPCSEA Regd. No. 1840/PO/
ReBi/S/5/CPCSEA), Government of India, and Institutional Animal 
Ethics Committee (IAEC).
Study groups and sampling
Male mice of the control group (n=6) were given distilled water as 
drinking water, and “treated group” (n=6) were administered 2 mg/kg 
body weight of endosulfan for 12 weeks. Blood samples were collected 
from the sacrificed mice and centrifuged to obtain serum samples for 
estimation of arsenic concentration. Testes from all the animals were 
removed and stored at -80°C for estimation of arsenic concentration 
and DNA methylation.
Atomic absorption spectrometer
Tissues of 6 controls and 6 arsenic-treated male mice stored at −80°C 
for estimation of arsenic concentration. Further, sample preparation 
and estimation of arsenic was done by standard protocol of atomic 
absorption spectrometer graphite flame (Perkin Elmer) model number 
AAN3160080 (PinnAAcle900T).
DNA isolation
The testes tissue of male mice was homogenized in liquid nitrogen with 
the help of mortar and pestle. DNA from the testes was extracted by 
standard protocol of DNA purification kit (Promega, Wizard Genomic 
DNA Purification Kit, A1120).
DNA methylation
The isolated DNA was stored at 2-4°C overnight and processed for DNA 
methylation next day. The DNA methylation was assessed with the help 
of MethylFlash Methylated DNA Quantification Kit (EPIGENTEK).
Statistical analysis
T-test was performed to generate significance of DNA methylation and 
two-way ANOVA for arsenic concentration in blood and testes. p<0.05 
was considered significance. Statistical analysis was performed with 
the help of SPSS 16.
RESULTS AND DISCUSSION
Blood and testes collected after dissection of the mice were used for 
estimation of arsenic concentration. The mean arsenic concentration 
in blood of arsenic-treated mice (316.36±43.607 ppb) was recorded 
to be higher than the mean arsenic concentration in blood of control 
group (1.005±0.885522 ppb). Similarly, the mean value of arsenic 
concentration in testes of arsenic-treated mice (128.3±31.423 ppb) 
was observed to be higher than that of arsenic concentration in testes 
of the control group (0.7±1.274 ppb) as shown in Fig. 1. Importantly, 
arsenic concentration in blood was significantly greater than in 
testes of arsenic-treated group and both higher than the control with 
significance value (*p<0.0001).
The isolated DNA from testes from each group was tested for the global 
methylation of active genes in the genome of mice. 0.457% of the mice 
genome was found to be methylated in the control group, and only 
0.21% of genome was methylated in arsenic-treated mice group with 
significance value (**p<0.0001) as shown in Fig. 2.
Ambiguous nature of arsenic, a deadly poison, a carcinogen, and 
antitumor capacity [16] makes it more interesting and hence rivets 
us to explore more to understand the elaborate mechanism by 
which it causes toxicity. Most satisfying mechanisms proposed for 
its carcinogenicity were by inducing double strand break leading to 
chromosomal aberration [17] and its capacity to induce changes in DNA 
methylation [9]. We have demonstrated how arsenic affects methylation 
of DNA on global genome.
Accumulation of arsenic in different organs in mice and humans is evident 
and has been reported several times in literature [5,6]. Exposure to arsenic 
has been observed to cause prostate cancer in humans and liver cancer in 
mice [18,19]. Mutation caused by arsenic has not been evident till date, 
but epigenetic changes by altering methylation of promoter of genes are 
superfluous in the literature [20-22]. Arsenic has also been shown to cause 
hypermethylation of tumor suppressor genes [18]. According to a recent 
report, hypomethylation of DNA was observed in the genome of mice 
exposed to low dose of arsenic for shorter period, and hypermethylation 
was recorded in mice with chronic exposure of arsenic [23].
In the current investigation, mice were exposed to arsenic contaminated 
water of 200,000 ppb daily for 3 months. The concentration of arsenic 
in testes of mice after 3 months was observed 128 ppb (Fig. 1). The 
accumulation of arsenic is in testes is high enough to cause epigenetic 
changes. <1% of genome contains exones in mammals that code for 
proteins and our data show only 0.21% cytosine methylation in arsenic-
treated mice as compared to 0.457% in control (Fig. 2). To convert 
inorganic arsenic to organic one, methyltransferase transfers the excess 
methyl group from CpG island of promoter to pentavalent or tetravalent 
arsenic. If arsenic is accumulated in higher concentration, the promoter 
region would so become hypomethylated as a consequence leading to 
altered gene expression which might include several oncogenes.
CONCLUSION
In the field of epigenetic study, arsenic is a potent toxic agent and 
carcinogen which leads to hypomethylation of oncogenes and 
Fig. 1: Arsenic concentration in blood and testes of arsenic-
treated mice and control with mean±standard deviation 
(*p<0.0001)
Fig. 2: Mean±standard deviation of percentage of global 
methylation in genome extracted from testes of control and 
arsenic-treated mice group (**p<0.0001)
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hypermethylation of tumor supressor genes. Acute exposure of arsenic 
for 3 months leads to global hypomethylation of DNA in mice. Since 
arsenic is accumulated in high concentration in testes, the genome 
becomes vulnerable to epigenetic changes. Apart from direct or 
indirect mutation in oncogene or tumor suppressor genes, epigenetic 
modification due to toxicity has emerged as a new and yet challenging 
mechanism of carcinogenesis which needs to be studied extensively.
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